GENinCode (LON:GENI) Shares Down 4.8% – Should You Sell?

GENinCode Plc (LON:GENI) shares dropped 4.8% during trading on Tuesday . The stock traded as low as GBX 1.02 and last traded at GBX 1.07. Approximately 4,913,231 shares changed hands during trading, a decline of 3% from the average daily volume of 5,059,487 shares. The stock had previously closed at GBX 1.13.

GENinCode Stock Performance

The company has a market cap of £7.62 million, a PE ratio of -0.45 and a beta of 0.62. The stock has a 50 day simple moving average of GBX 1.30 and a two-hundred day simple moving average of GBX 2.28. The company has a debt-to-equity ratio of 7.17, a current ratio of 2.80 and a quick ratio of 15.89.

GENinCode Company Profile

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies. GENinCode CE marked invitro-diagnostic molecular tests combine clinical algorithms and bioinformatics to provide advanced patient risk assessment to predict disease onset.